Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 23;13(8):e0202830.
doi: 10.1371/journal.pone.0202830. eCollection 2018.

DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials

Affiliations

DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials

Sara Paparini et al. PLoS One. .

Abstract

Pre-exposure prophylaxis (PrEP) with antiretroviral medication is an effective, evidence-based option for HIV prevention. In England, issues of cost-effectiveness and of responsibility for commissioning prevention services have so far led National Health Service (NHS) England to decide not to commission PrEP. Given the significant lag between the awareness of PrEP efficacy and the opportunity to obtain PrEP through traditional health care routes, many gay and other men who have sex with men (MSM) have turned to 'DIY PrEP', purchasing generic formulations of PrEP for themselves on the internet or via other alternative routes. However, there is very little research on DIY PrEP practices and no qualitative study with DIY PrEP users in the UK. A formative qualitative study was conducted in 2017 to inform the development of an intervention (PrEP Club) to support DIY PrEP users and improve the safety and experience of this prevention strategy. Focus groups were held with 20 MSM who are based in London and are obtaining PrEP through means other than clinical trials, to explore their accounts of sourcing and using PrEP and the experiential meanings of these. In this article, we report findings from this first, formative study and present the different practices involved in finding out about PrEP, buying it and ascertaining legitimacy of sellers and products. We reflect on the uncertainties participants described related to actually using PrEP, including deciding on drug dosing and monitoring their health. Finally, we present the results of the discussions participants had about the kind of support they had received, the help they would have liked, and their views on proposed interventions to support DIY PrEP users, such as PrEP Club.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist. SP has received speaker honoraria from ViiV HealthCare. JA has received speaker honoraria from Gilead Science, Merck Sharp Dohm, conference attendance support and consultancy fees from Gilead Sciences. VKN has received speaker honoraria from Gilead France. WN is the founder of PrEPster, a community based organisations that has received grants from MAC Aids Fund, Elton John AIDS Foundation, and Public Health England. WN has received personal travel grants from AVAC and speaker honoraria from the Thai Red Cross. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

References

    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010; 363(27):2587–99. 10.1056/NEJMoa1011205 - DOI - PMC - PubMed
    1. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet. 2016; 387(10013):53–60. - PMC - PubMed
    1. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine. 2015; 373(23):2237–46. 10.1056/NEJMoa1506273 - DOI - PubMed
    1. Cáceres CF, Borquez A, Klausner JD, Baggaley R, Beyrer C. Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy. Journal of the International AIDS Society. 2016. October 1;19(7S6). - PMC - PubMed
    1. NHS England. Update on commissioning and provision of Pre-Exposure Prophylaxis (PREP) for HIV prevention. 21 March 2016. https://www.england.nhs.uk/2016/03/prep/

Publication types